// App-Quantinova.ai

2908-04 : PHARMACODYNAMIC CONSIDERATIONS AND CLINICAL IMPACT OF DUAL ANTIPLATELET THERAPY INTERRUPTION AFTER RESOLUTE ZOTAROLIMUS-ELUTING STENT IMPLANTATION

Researchers

Presenter

  • David Kandzari

Principal Investigators

  • Sigmund Silber

  • Stephan Windecker

  • Sandeep Brar

  • Lilian Lee

  • Ajay Kirtane

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved